Denali Therapeutics Inc. logo

Denali Therapeutics Inc.

DNLI | NASDAQ
Chart Builder DCF Calculator
$21.46
+$0.99 (+4.84%)
Sep 22, 2026, 12:43 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
205.33M 174.96M 127.11M 218.04M 293.48M 507.14M
Short-Term Investments
662.55M 657.37M 907.41M 1.12B 571.93M 962.55M
Long-Term Investments
98.32M 359.37M n/a 1.5M 425.45M 34.2M
Other Long-Term Assets
25.94M 24.74M 18.14M 11.9M 11.87M 962K
Receivables
2.18M 2.17M 3.42M 9.28M 1.23M n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
30.6M n/a n/a n/a n/a 25.96M
Total Current Assets
900.66M 864.44M 1.06B 1.37B 897.23M 1.5B
Property-Plant & Equipment
119.94M 125.63M 71.64M 74.52M 69.61M 73.46M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
244.2M 509.74M 89.78M 87.92M 506.93M 108.63M
Total Assets
1.14B 1.37B 1.15B 1.46B 1.4B 1.6B
Account Payables
3.33M 11.14M 9.48M 2.79M 4.78M 1.07M
Deferred Revenue
n/a n/a n/a 290.05M 320.3M 23.48M
Short-Term Debt
n/a n/a n/a n/a n/a 4.69M
Other Current Liabilities
53.28M 38.86M 21.59M 17.09M 19.01M 21.95M
Total Current Liabilities
98.35M 102.21M 77.98M 363.92M 378.25M 71.7M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
5.53M 5.62M n/a 379K 379K 701K
Total Long-Term Liabilities
32.74M 42.29M 44.98M 53.89M 63.63M 382.05M
Total Liabilities
131.09M 144.5M 122.96M 417.81M 441.87M 453.75M
Total Debt
36.76M 48.71M 52.24M 60.35M 64.01M 68.87M
Book Value
1.01B 1.23B 1.03B 1.04B 962.29M 1.15B
Book Value Per Share
5.78 7.48 7.50 8.30 7.92 10.21
Common Stock
1.89M 1.77M 1.71M 1.69M 1.55M 1.53M
Retained Earnings
-2.05B -1.54B -1.12B -970.99M -645M -354.42M
Comprehensive Income
682K 2.02M 643K -6.89M -2.5M -245K
Shareholders Equity
1.01B 1.23B 1.03B 1.04B 962.29M 1.15B
Total Investments
760.88M 1.02B 907.41M 1.12B 997.38M 996.75M

© 2026 bestshares.com. All rights reserved.